Literature DB >> 6663610

Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia.

L Tardella, L Rossetti, R De Pirro, A Camagna, F Leonetti, G Tamburrano, M Merli, F Rossi Fanelli, R Lauro.   

Abstract

A 46-year-old female patient suffering from Lupus Nephritis came to our attention in 1981 for severe recurrent hypoglycaemia; she was obliged to eat every 5-7 hr to maintain glucose values not below 1.3-1.6 mM. All known causes of hypoglycaemia were excluded by performing selective angiography of the pancreas and skull, chest and abdominal computerized tomography, as well as stimulation and suppression tests. Oral glucose tolerance, tolbutamide and intravenous insulin (0.4 U/Kg b.w.) tests demonstrated that the patient was highly insulin resistant; furthermore, studies on the patient's red blood cells suggested that her insulin receptors were completely unable to bind insulin. Studies carried out to reveal the reason for this binding inhibition demonstrated that red blood cells from normal subjects as well as adipocytes from normal rats incubated with the patient's serum did not bind insulin (50% inhibition occurring at about 1:30 serum dilution). Insulin binding inhibitors were found in the fraction of the serum precipitated by ammonium sulphate. The serum cleared of IgG fraction was unable to affect insulin binding. These data demonstrate that the serum from the female patient investigated contained anti-insulin receptor antibodies blocking the binding of insulin to its receptors. Plasmapheresis improved the patient's metabolic status. The clinical picture would suggest that recurrent hypoglycaemia was caused by anti-insulin receptor antibodies acting as insulin on target cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6663610

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  4 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Systemic lupus erythematosus presenting as hypoglycemia with insulin receptor antibodies.

Authors:  R L Howard; L K Beck; A Schneebaum
Journal:  West J Med       Date:  1989-09

3.  Clinical evaluation of insulin resistance and beta-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus.

Authors:  Tim K Tso; Hui-Yu Huang; Chen-Kang Chang; Ying-Ju Liao; Wen-Nan Huang
Journal:  Clin Rheumatol       Date:  2004-05-18       Impact factor: 2.980

4.  PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels.

Authors:  Maria Crespo-Masip; Aurora Pérez-Gómez; Carla Guzmán; Sandra Rayego; Nuria Doladé; Alicia García-Carrasco; Ramiro Jover; José Manuel Valdivielso
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-25       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.